Case Study: Boehringer Ingelheim improves clinical trial efficiency with Veeva Clinical Operations

Boehringer Ingelheim reduces reporting effort by 50% with Veeva

Boehringer Ingelheim, a large biopharma company, sought to modernize its global clinical operations. The challenge was managing over 600 simultaneous trials efficiently, which required better integration of documents, team workflows, and collaboration with sites. To address this, the company partnered with vendor Veeva Systems to adopt a unified clinical operations platform.

Veeva implemented its Veeva Clinical Operations suite, which included solutions like Veeva CTMS and Veeva eTMF. This created a single, connected environment that provided end-to-end visibility for study teams. The solution streamlined collaboration and execution of complex trials. As a result, Boehringer Ingelheim achieved a 50% reduction in reporting effort and greater speed and consistency across its global operations.

Boehringer Ingelheim